Cancer BiologybioRxivPreprint
Synergistic effects of inhibitors targeting PI3K and Aurora Kinase A in preclinical inflammatory breast cancer models
Nadia Al Ali, Jacob LK Kment, Stephanie Young, Andrew W. Craig
This study shows that combining PI3K and AURKA inhibitors synergistically kills IBC cells and reduces tumor growth and metastasis in xenograft models.
DOI 10.1101/2023.08.11.552992